V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20200942 | 20167040 | 1.81 | 43.3 | null | 2021-05-05 | 2021-05-19 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100711195 |
| 20200947 | 20167041 | 1.72 | 86.4 | Palliative (P) | 2019-12-12 | 2019-12-12 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101192441 |
| 20200957 | 20167042 | 1.67 | 55.4 | Palliative (P) | null | 2019-05-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100607702 |
| 20200970 | 20167043 | 1.62 | 60.7 | Palliative (P) | 2016-06-09 | 2016-07-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100427542 |
| 20200977 | 20167044 | 1.83 | 48 | null | 2018-02-13 | 2018-02-24 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100928270 |
| 20200989 | 20167045 | 1.63 | 76.4 | null | 2017-04-01 | 2017-04-05 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100399104 |
| 20200996 | 20167046 | 1.66 | 69.8 | Palliative (P) | null | 2016-05-28 | Docetaxel | 02 | N | DOCETAXEL | 100366524 |
| 20201011 | 20167047 | 1.69 | 62.8 | null | 2019-07-18 | 2019-08-13 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 101363677 |
| 20201013 | 20167048 | 1.62 | 110 | Palliative (P) | 2020-08-18 | 2020-08-24 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100334341 |
| 20201029 | 20167049 | 1.74 | 100 | Palliative (P) | 2020-01-30 | 2020-02-02 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100189151 |
| 20201092 | 20167050 | 1.74 | 82.5 | Palliative (P) | 2020-03-12 | 2020-03-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101702671 |
| 20201094 | 20167051 | 1.6 | 52.3 | null | 2021-11-01 | 2021-11-13 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100840345 |
| 20201099 | 20167052 | 1.65 | 67.4 | Palliative (P) | 2019-04-25 | 2019-10-10 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101602249 |
| 20201109 | 20167053 | 1.67 | 66.3 | Palliative (P) | 2016-11-21 | 2016-12-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101373134 |
| 20201127 | 20167054 | 1.67 | 83.1 | Palliative (P) | 2021-01-30 | 2021-01-30 | Cetuximab + FOLFIRI cycle1 | 02 | N | CAPECITABINE + GEMCITABINE | 100472059 |
| 20201136 | 20167055 | 1.86 | 43.4 | null | 2019-06-15 | 2019-06-22 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100283382 |
| 20201138 | 20167056 | 1.83 | 72.6 | Palliative (P) | 2021-08-05 | 2021-08-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101365550 |
| 20201172 | 20167057 | 1.56 | 38.7 | null | 2019-05-05 | 2019-05-23 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101436644 |
| 20201173 | 20167058 | 1.8 | 70.1 | Adjuvant (A) | 2022-03-08 | 2022-03-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101144066 |
| 20201178 | 20167059 | 1.83 | 98.2 | Palliative (P) | 2017-11-13 | 2020-06-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101492413 |
| 20201186 | 20167060 | 1.66 | 93.5 | Palliative (P) | null | 2016-11-23 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101590180 |
| 20201188 | 20167061 | 1.87 | 98 | null | 2019-11-25 | 2020-04-04 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101210292 |
| 20201194 | 20167062 | 1.58 | 82 | Palliative (P) | 2021-10-02 | 2021-11-08 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100961568 |
| 20201202 | 20167063 | 1.74 | 46 | Palliative (P) | 2018-11-22 | 2018-12-02 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101825175 |
| 20201206 | 20167064 | 1.6 | 55.5 | Palliative (P) | 2018-10-16 | 2018-10-24 | Cetuximab + FOLFIRI cycle1 | 02 | N | DOCETAXEL | 100450332 |
| 20201210 | 20167065 | 1.78 | 62.5 | Palliative (P) | 2019-12-31 | 2019-12-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101777143 |
| 20201212 | 20167066 | 1.97 | 89.2 | null | 2018-06-16 | 2018-06-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 100981626 |
| 20201214 | 20167067 | 1.69 | 64 | Palliative (P) | null | 2020-01-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100699634 |
| 20201222 | 20167068 | 1.85 | null | Palliative (P) | 2015-11-15 | 2016-04-30 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101238638 |
| 20201240 | 20167069 | 1.71 | 105.4 | Palliative (P) | 2020-02-05 | 2020-03-12 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100481973 |
| 20201253 | 20167070 | 1.7 | 64 | null | null | 2020-09-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100545499 |
| 20201294 | 20167071 | 1.58 | 74.8 | null | 2022-02-04 | 2022-02-22 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101530871 |
| 20201315 | 20167072 | 1.71 | 85.5 | Palliative (P) | 2022-03-17 | 2022-03-17 | Docetaxel | 02 | N | DOCETAXEL | 100341284 |
| 20201319 | 20167073 | 1.6 | 81.15 | null | 2022-01-22 | 2022-02-03 | CETUXIMAB + IRINOTECAN + MDG | 2 | null | CAPECITABINE + GEMCITABINE | 100363025 |
| 20201354 | 20167074 | 1.7 | 79.4 | Palliative (P) | 2021-07-03 | 2021-07-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100696717 |
| 20201356 | 20167075 | 1.59 | 77.65 | Palliative (P) | 2020-02-12 | 2020-03-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100830476 |
| 20201358 | 20167076 | 1.59 | 53.5 | null | 2017-10-13 | 2017-10-14 | CAPECITABINE + GEMCITABINE | N | null | CAPECITABINE + GEMCITABINE | 101603266 |
| 20201371 | 20167077 | 1.7 | 51.7 | Palliative (P) | 2020-04-09 | 2020-04-29 | Gemcitabine + Capecitabine | 01 | null | CAPECITABINE + GEMCITABINE | 101643879 |
| 20201381 | 20167078 | 1.69 | 72.6 | null | 2020-04-16 | 2020-04-17 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100651204 |
| 20201387 | 20167079 | 1.8 | 76 | null | 2011-10-28 | 2016-12-04 | Docetaxel | 02 | N | DOCETAXEL | 100421570 |
| 20201412 | 20167080 | 1.7 | 71 | Adjuvant (A) | 2016-09-06 | 2016-09-07 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101165809 |
| 20201413 | 20167081 | 1.59 | 50.4 | Palliative (P) | 2018-10-30 | 2018-10-30 | Cetuximab + FOLFIRI cycle1 | 02 | N | DOCETAXEL | 101548615 |
| 20201441 | 20167082 | 1.7 | 55.3 | Palliative (P) | 2020-06-07 | 2020-06-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100077601 |
| 20201448 | 20167083 | 1.83 | 82.1 | null | 2019-01-17 | 2019-02-08 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101371450 |
| 20201460 | 20167084 | 1.66 | 57.5 | Palliative (P) | 2017-12-18 | 2018-01-02 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100773791 |
| 20201467 | 20167085 | 1.5 | 69.3 | null | 2020-02-02 | 2020-02-13 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101019305 |
| 20201473 | 20167086 | 1.62 | 60 | null | 2021-03-02 | 2021-03-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101176543 |
| 20201481 | 20167087 | 1.77 | 65.5 | Adjuvant (A) | 2021-06-02 | 2022-01-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101345261 |
| 20201522 | 20167088 | 1.81 | 69.3 | Palliative (P) | null | 2021-12-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101364506 |
| 20201523 | 20167089 | 1.7 | 72 | Palliative (P) | 2017-11-22 | 2017-12-01 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100920309 |